Tiger Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-137,728
| Closed | -$1.24M | – | 38 |
|
2022
Q1 | $1.24M | Hold |
137,728
| – | – | 0.2% | 27 |
|
2021
Q4 | $1.91M | Hold |
137,728
| – | – | 0.37% | 22 |
|
2021
Q3 | $1.47M | Hold |
137,728
| – | – | 0.27% | 29 |
|
2021
Q2 | $1.24M | Hold |
137,728
| – | – | 0.22% | 30 |
|
2021
Q1 | $1.46M | Hold |
137,728
| – | – | 0.29% | 29 |
|
2020
Q4 | $1.74M | Hold |
137,728
| – | – | 0.39% | 26 |
|
2020
Q3 | $1.21M | Hold |
137,728
| – | – | 0.34% | 31 |
|
2020
Q2 | $1.34M | Hold |
137,728
| – | – | 0.37% | 26 |
|
2020
Q1 | $397K | Hold |
137,728
| – | – | 0.13% | 36 |
|
2019
Q4 | $529K | Hold |
137,728
| – | – | 0.15% | 22 |
|
2019
Q3 | $545K | Hold |
137,728
| – | – | 0.21% | 21 |
|
2019
Q2 | $580K | Hold |
137,728
| – | – | 0.24% | 19 |
|
2019
Q1 | $945K | Sell |
137,728
-25,000
| -15% | -$172K | 0.26% | 18 |
|
2018
Q4 | $599K | Hold |
162,728
| – | – | 0.15% | 24 |
|
2018
Q3 | $1.03M | Hold |
162,728
| – | – | 0.1% | 51 |
|
2018
Q2 | $1.23M | Hold |
162,728
| – | – | 0.25% | 39 |
|
2018
Q1 | $1.3M | Hold |
162,728
| – | – | 0.17% | 47 |
|
2017
Q4 | $1.82M | Hold |
162,728
| – | – | 0.28% | 29 |
|
2017
Q3 | $1.89M | Sell |
162,728
-1
| -0% | -$12 | 0.34% | 32 |
|
2017
Q2 | $1.57M | Hold |
162,729
| – | – | 0.31% | 32 |
|
2017
Q1 | $1.9M | Hold |
162,729
| – | – | 0.36% | 32 |
|
2016
Q4 | $1.46M | Hold |
162,729
| – | – | 0.26% | 30 |
|
2016
Q3 | $5.29M | Hold |
162,729
| – | – | 1.25% | 16 |
|
2016
Q2 | $2.99M | Hold |
162,729
| – | – | 0.97% | 19 |
|
2016
Q1 | $2.71M | Hold |
162,729
| – | – | 0.68% | 28 |
|
2015
Q4 | $5.04M | Hold |
162,729
| – | – | 0.65% | 26 |
|
2015
Q3 | $8.44M | Buy |
+162,729
| New | +$8.44M | 1.13% | 23 |
|